Clinical Trial Update: Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication [NA]

View source ↗

Summary

A completed clinical trial evaluated levofloxacin-containing regimens as second-line therapy for Helicobacter pylori eradication, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Helicobacter Pylori Infection | NA | Status: COMPLETED | Results posted: 2016-11-04